文献速递乳腺癌支持与姑息治疗

iCanDecide随机临床试验:改善乳腺癌手术决策

Improving Breast Cancer Surgical Treatment Decision Making: The iCanDecide Randomized Clinical Trial.
PubMed 文献 · J Clin Oncol · 2018-01-24

本研究纳入537例早期乳腺癌患者,随机分配至交互式定制网站(干预组)或静态网站(对照组),评估局部区域治疗决策质量。两组价值观一致性决策比例无显著差异。

要点

  • 交互式定制决策工具提高高质量决策率,主要由知识提升驱动
  • 两组价值观一致性决策比例均较高(78.6% vs 81.4%)
  • 干预组决策准备度更高,其他决策评价无显著差异

核心结论

  • 交互式定制iCanDecide网站通过改善知识水平正向影响高质量决策,优于静态在线信息。

研究设计与样本

  • 随机临床试验,从22个外科实践招募537例新诊断早期乳腺癌患者,随机分配至交互式定制网站(干预组)或静态网站(对照组)。

主要发现

  • 两组价值观一致性决策比例分别为78.6%(干预组)和81.4%(对照组)。
  • 干预效果在入组时强烈倾向某治疗选项的女性与无强烈倾向者中相似。

临床怎么用

  • 面向患者的决策工具应整合到临床工作流程中以改善决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose This study was conducted to determine the effect of iCanDecide, an interactive and tailored breast cancer treatment decision tool, on the rate of high-quality patient decisions-both informed and values concordant-regarding locoregional breast cancer treatment and on patient appraisal of decision making. Methods We conducted a randomized clinical trial of newly diagnosed patients with early-stage breast cancer making locoregional treatment decisions. From 22 surgical practices, 537 patients were recruited and randomly assigned online to the iCanDecide interactive and tailored Web site (intervention) or the iCanDecide static Web site (control). Participants completed a baseline survey and were mailed a follow-up survey 4 to 5 weeks after enrollment to assess the primary outcome of a high-quality decision, which consisted of two components, high knowledge and values-concordant treatment, and secondary outcomes (decision preparation, deliberation, and subjective decision quality). Results Patients in the intervention arm had higher odds of making a high-quality decision than did those in the control arm (odds ratio, 2.00; 95% CI, 1.37 to 2.92; P = .0004), which was driven primarily by differences in the rates of high knowledge between groups. The majority of patients in both arms made values-concordant treatment decisions (78.6% in the intervention arm and 81.4% in the control arm). More patients in the intervention arm had high decision preparation (estimate, 0.18; 95% CI, 0.02 to 0.34; P = .027), but there were no significant differences in the other decision appraisal outcomes. The effect of the intervention was similar for women who were leaning strongly toward a treatment option at enrollment compared with those who were not. Conclusion The tailored and interactive iCanDecide Web site, which focused on knowledge building and values clarification, positively affected high-quality decisions largely by improving knowledge compared with static online information. To be effective, future patient-facing decision tools should be integrated into the clinical workflow to improve decision making.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Hawley ST, Li Y, An LC, et al. Improving Breast Cancer Surgical Treatment Decision Making: The iCanDecide Randomized Clinical Trial. J Clin Oncol. 2018. PMID: 29364772. doi:10.1200/JCO.2017.74.8442

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。